ABSTRACT
This revised textbook examines the most important aspects of multiple sclerosis that impact on clinical trial design, on the development of new disease therapies, and, most importantly, on patient care. An international team of contributors discusses the clinical course of multiple sclerosis, its clinical heterogeneity, and the presence of subclini
TABLE OF CONTENTS
part I|2 pages
Introduction
part II|1 pages
Biological responses to type I interferons: relationship to therapeutic effects in multiple sclerosis
part III|1 pages
Clinical trials of disease-modifying therapy
part IV|1 pages
Disease-modifying drug therapy in clinical practice
